Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Masayoshi Koyasu"'
Autor:
Shinji Ishikawa, Kenji Takemoto, Masayoshi Koyasu, Akihiro Masuda, Masato Watarai, Rei Shibata, Toyoaki Murohara, Yuta Katsumi, Takayuki Mitsuda, Yusuke Uemura
Publikováno v:
Journal of Cardiac Failure. 26:566-573
Background Undernutrition is a negative predictor of adverse outcomes in patients with heart failure (HF). Despite the survival advantage of elevated body mass index (BMI) in patients with HF, BMI does not necessarily reflect a favorable nutritional
Autor:
Masato Watarai, Rei Shibata, Kenji Takemoto, Masayoshi Koyasu, Shinji Ishikawa, Toyoaki Murohara, Yusuke Uemura
Publikováno v:
Circulation Journal. 82:2793-2799
BACKGROUND Hospitalization for heart failure (HF) carries a risk of impairment in physical activity. We assessed the association between changes in Barthel index (BI) during hospitalization and prognosis in patients with acute HF. Methods and Results
Autor:
Ryo Imai, Masato Watarai, Hideki Ishii, Takashi Watanabe, Shinji Ishikawa, Satoshi Iwamiya, Yusuke Uemura, Takayuki Mitsuda, Ayako Miura, Kenji Takemoto, Tomohiro Uchikawa, Toyoaki Murohara, Yuta Ozaki, Masayoshi Koyasu
Publikováno v:
Internal Medicine
Intramyocardial dissecting hematoma is a rare but potentially fatal complication of myocardial infarction. The decision to adopt a surgical or conservative strategy may depend on the clinical and hemodynamic stability of patients. Regardless, the pre
Autor:
Kenji Takemoto, Takayuki Mitsuda, Akihito Tanaka, Masayoshi Koyasu, Toyoaki Murohara, Hideki Ishii, Yusuke Uemura, Masato Watarai
Publikováno v:
JACC: Cardiovascular Interventions. 12:e199-e200
A 72-year-old woman presented with intermittent chest oppression. She had undergone coronary artery bypass surgery with saphenous vein graft to the left anterior descending artery 36 years ago. Emergent coronary angiography showed a radiolucent area
Autor:
Hideki Ishii, Akihito Tanaka, Shinji Ishikawa, Takayuki Mitsuda, Masato Watarai, Masayoshi Koyasu, Toyoaki Murohara, Kenji Takemoto, Yusuke Uemura, Rei Shibata
Publikováno v:
Coronary artery disease. 30(8)
The causal relationship of lipoprotein(a) with cardiovascular disease has been established. However, clinical impacts of lipoprotein(a) levels on adverse vascular events in patients with established coronary artery disease who are undergoing statin t
Autor:
Yusuke, Uemura, Kenji, Takemoto, Masayoshi, Koyasu, Shinji, Ishikawa, Hideki, Ishii, Toyoaki, Murohara, Masato, Watarai
Publikováno v:
Nagoya Journal of Medical Science
Neointimal calcification after stent implantation has been reported as one of the forms of neoatherosclerosis. There are a few patients with in-stent restenosis (ISR) and an undilatable calcified neointima who require rotational atherectomy to achiev
Autor:
Takayuki Mitsuda, Ayako Miura, Hiroki Watanabe, Masato Watarai, Yusuke Uemura, Tomohiro Uchikawa, Toyoaki Murohara, Rei Shibata, Kenji Takemoto, Ryo Imai, Masayoshi Koyasu
Publikováno v:
Journal of Cardiology. 67:268-273
Background Increased red blood cell distribution width (RDW) is associated with adverse outcomes in heart failure. In the present study, we assessed the association between changes in RDW values during hospitalization and long-term prognosis in patie
Autor:
Toyoaki Murohara, Yusuke Uemura, Takanori Miura, Masato Watarai, Ryo Imai, Rei Shibata, Takayuki Mitsuda, Kenji Takemoto, Tomohiro Kato, Masayoshi Koyasu, Shinji Ishikawa, Yuta Ozaki, Ayako Miura, Tomohiro Uchikawa, Satoshi Iwamiya
Publikováno v:
Heart and Vessels. 31:1643-1649
Tolvaptan, a vasopressin type 2 receptor antagonist, has an aquaretic effect without affecting renal function. The effects of long-term tolvaptan administration in heart failure patients with renal dysfunction have not been clarified. Here, we assess
Autor:
Kenji Takemoto, Toyoaki Murohara, Shinji Ishikawa, Tsubasa Teraoka, Rei Shibata, Masato Watarai, Tomohiro Uchikawa, Ryo Imai, Takashi Watanabe, Masayoshi Koyasu, Yusuke Uemura, Yuta Ozaki
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 81(11)
Background We assessed the long-term safety and efficacy of tolvaptan in 102 patients with heart failure (HF) and chronic kidney disease (CKD). Median follow-up duration was 1.6 years (1.0-4.4 years).Methods and Results:One patient discontinued tolva
Autor:
Masato Watarai, Masayoshi Koyasu, Satoshi Iwamiya, Tomohiro Uchikawa, Yusuke Uemura, Yuta Ozaki, Shinji Ishikawa, Ryo Imai, Takahiro Okumura, Rei Shibata, Kenji Takemoto, Toyoaki Murohara
Publikováno v:
Journal of cardiology. 70(6)
Background The prognostic impact of red blood cell distribution width (RDW) on adverse outcomes in patients with heart failure with preserved ejection fraction (HFpEF) is unclear. We investigated the association between RDW values at admission and lo